Child and adolescent mood disorders - Experience with serotonin- based therapies

Biological Psychiatry

Volumn 44, Issue 5, 1998, Pages 336-340

  Ryan, Neal D ^a   Varma, Deep ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescence; Child; Depressive disorder; Serotonin uptake inhibitors

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; MOOD; NORADRENERGIC SYSTEM; OBSESSION; ONSET AGE; PHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; STRESS;

EID: 0031718567     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00163-2     Document Type: Review

References (46)

1. Anderson I. Place of tricyclics in depression of young people is not proved. BMJ. 311:1995;390.
2. Anderson I., Tomenson B. The efficacy of selective serotonin reuptake inhibitors in depression A meta-analysis of studies against tricyclic antidepressants . J Psychopharmacol. 8:1994;238-249.
3. Apter A., Ratzoni G., King R.A., et al. Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry. 33:1994;342-348.
4. Birmaher B., Waterman G.S., Ryan N., et al. Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 33:1994;993-999.
5. Birmaher B., Ryan N.D., Williamson D.E., Brent D.A., Kaufman J. Childhood and adolescent depression A review of the past 10 years. Part II . J Am Acad Child Adolesc Psychiatry. 35:1996;1575-1583.
6. Birmaher B., Ryan N.D., Williamson D.E., et al. Childhood and adolescent depression A review of the past 10 years. Part I . J Am Acad Child Adolesc Psychiatry. 35:1996;1427-1439.
7. Boulos C., Kutcher S., Gardner D., Young E. An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. J Child Adolesc Psychopharmacol. 2:1992;103-111.
8. Brent D.A., Holder D., Kolko D., et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry. 54:1997;877-885.
9. Clarke A.S., Kammerer C.M., George K.P., et al. Evidence for heritability of biogenic amine levels in the cerebrospinal fluid of rhesus monkeys. Biol Psychiatry. 38:1995;572-577.
10. Coplan J.D., Andrews M.W., Rosenblum L.A., et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors Implications for the pathophysiology of mood and anxiety disorders . Proc Natl Acad Sci USA. 93:1996;1619-1623.
11. Emslie G., Rush A., Weinberg W., et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 54:1997;1031-1037.
12. Flament M.F., Koby E., Rapoport J.L., et al. Childhood obsessive-compulsive disorder A prospective follow-up study . J Child Psychol Psychiatry. 31:1990;363-380.
13. Geller B., Cooper T.B., McCombs H.G., Graham D., Wells J. Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design. Psychopharmacol Bull. 25:1989;101-108.
14. Geller B., Cooper T.B., Graham D.L., Marsteller F.A., Bryant D.M. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull. 26:1990;85-90.
15. Harrington R., Fudge H., Rutter M., Pickles A., Hill J. Adults outcomes of childhood and adolescent depression. I. Psychiatric status. Arch Gen Psychiatry. 47:1990;465-473.
16. Hazell P., O'Connell D., Heathcote D., Robertson J., Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression A meta-analysis . BMJ. 310:1995;897-901.
17. Higley J.D., Suomi S.J., Linnoila M. CSF monoamine metabolite concentrations vary according to age, rearing, and sex,and are influenced by the stressor of social separation in rhesus monkeys. Psychopharmacology (Berl). 103:1991;551-556.
18. Higley J.D., Suomi S.J., Linnoila M. A longitudinal assessment of CSF monoamine metabolite and plasma cortisol concentrations in young rhesus monkeys. Biol Psychiatry. 32:1992;127-145.
19. Higley J.D., Thompson W.W., Champoux M., et al. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Arch Gen Psychiatry. 50:1993;615-623.
20. Hughes C.W., Preskorn S.H., Weller E., Weller R., Hassanein R., Tucker S. The effect of concomitant disorders in childhood depression on predicting treatment response. Psychopharmacol Bull. 26:1990;235-238.
21. Jain U., Birmaher B., Garcia M., Al-Shabbout M., Ryan N. Fluoxetine in children and adolescents with mood disorders A chart review of efficacy and adverse effects . J Child Adolesc Psychopharmacol. 2:1992;259-265.
22. Kashani J.H., Shekim W.O., Reid J.C. Amitriptyline in children with major depressive disorder A double-blind crossover pilot study . J Am Acad Child Psychiatry. 23:1984;348-351.
23. Klein R.G., Koplewicz H.S., Kanner A. Imipramine treatment of children with separation anxiety disorder. J Am Acad Child Adolesc Psychiatry. 31:1992;21-28.
24. Kovacs M., Feinberg T.L., Crouse-Novak M., Paulauskas S.L., Pollock M., Finkelstein R. Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry. 41:1984;643-649.
25. Kovacs M., Feinberg T.L., Crouse-Novak M.A., Paulauskas S.L., Finkelstein R. Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry. 41:1984;229-237.
26. Kraemer G.W., Ebert M.H., Schmidt D.E., McKinney W.R. A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys. Neuropsychopharmacology. 2:1989;175-189.
27. Kramer A.D., Feiguine R.J. Clinical effects of amitriptyline in adolescent depression. A pilot study. J Am Acad Child Psychiatry. 20:1981;636-644.
28. Kutcher S., Boulos C., Ward B., et al. Response to desipramine treatment in adolescent depression A fixed-dose, placebo-controlled trial . J Am Acad Child Adolescent Psychiatry. 33:1994;686-694.
29. Kye C.H., Waterman G.S., Ryan N.D., et al. A randomized, controlled trial of amitriptyline in the acute treatment of a major depression. J Am Acad Child Adolesc Psychiatry. 35:1996;1139-1144.
30. Leonard H., Swedo S., Rapoport J.L., Coffey M., Cheslow D. Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine A double-blind crossover comparison . Psychopharmacol Bull. 24:1988;93-95.
31. Leonard H.L., Swedo S.E., Rapoport J.L., et al. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry. 46:1989;1088-1092.
32. Leonard H.L., Swedo S.E., Lenane M.C., et al. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry. 48:1991;922-927.
33. Petti T.A., Law W.D. Imipramine treatment of depressed children A double-blind pilot study . J Clin Psychopharmacol. 2:1982;107-110.
34. Preskorn S.H., Weller E.B., Hughes C.W., Weller R.A., Bolte K. Depression in prepubertal children Dexamethasone nonsuppression predicts differential response to imipramine vs. placebo . Psychopharmacol Bull. 23:1987;128-133.
35. Puig-Antich J., Perel J.M., Lupatkin W., et al. Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry. 44:1987;81-89.
36. Puig-Antich J., Goetz D., Davies M., et al. A controlled family history study of prepubertal major depressive disorder. Arch Gen Psychiatry. 46:1989;406-418.
37. Rao U., Weissman M.M., Martin J.A., Hammond R.W. Childhood depression and risk of suicide A preliminary report of a longitudinal study . J Am Acad Child Adolesc Psychiatry. 32:1993;21-27.
38. Rao U., Ryan N.D., Birmaher B., et al. Unipolar depression in adolescents Clinical outcome in adulthood . J Am Acad Child Adolesc Psychiatry. 34:1995;566-578.
39. Rao U., Dahl R.E., Ryan N.D., et al. The relationship between longitudinal clinical course and sleep and cortisol changes in adolescent depression. Biol Psychiatry. 40:1996;474-484.
40. Rosenblum L.A., Coplan J.D., Friedman S., Bassoff T., Gorman J.M., Andrews M.W. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biol Psychiatry. 35:1994;221-227.
41. Ryan N.D., Puig-Antich J., Ambrosini P., et al. The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry. 44:1987;854-861.
42. Ryan N.D., Birmaher B., Perel J.M., et al. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal children. Arch Gen Psychiatry. 49:1992;843-851.
43. Ryan N.D., Dahl R.E., Birmaher B., et al. Stimulatory tests of growth hormone secretion in prepubertal major depression Depressed versus normal children . J Am Acad Child Adolesc Psychiatry. 33:1994;824-833.
44. Sallee F.R., Vrindavanam N.S., Deas-Nesmith D., Carson S.W., Sethuraman G. Pulse intravenous clomipramine for depressed adolescents Double-blind, controlled trial . Am J Psychiatry. 154:1997;668-673.
45. Simeon J.G., Dinicola V.F., Ferguson H.B., Copping W. Adolescent depression A placebo-controlled fluoxetine treatment study and follow-up . Prog Neuropsychopharmacol Biol Psychiatry. 14:1990;791-795.
46. Williamson D.E., Ryan N.D., Birmaher B., et al. A case-control family history study of depression in adolescents. J Am Acad Child Adolesc Psychiatry. 34:1995;1596-1607.